OZEM Roundhill GLP-1 & Weight Loss ETF Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
17:19
Aug 18
Aug 18
Branded GLP-1 prices compress toward $40
GLP-1 therapies can be manufactured and delivered profitably for $40-$50 per month; prices will fall from $150-$200 to $99, then $79, and likely $40-$50 by 2030 because competition from new entrants and semaglutide patent expiration will compress branded pricing.
HIGH
19:04
Apr 21
Apr 21
Short weight-loss/GLP-1 sector names (proxied by OZEM) as McCullough maintains an ongoing short.
Short weight-loss/GLP-1 sector names (proxied by OZEM) as McCullough maintains an ongoing short position in the space, implying continued bearish conviction on the category.
MED
About OZEM Analyst Coverage
Buzzberg tracks OZEM (Roundhill GLP-1 & Weight Loss ETF) across 2 sources. 0 bullish vs 1 bearish calls from 2 analysts. Sentiment: mixed to bearish. 2 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: Andrew Dudum, Keith McCullough.